A Bolton teacher has spent years creating a free maths book to give pupils and parents an extra helping hand with their education.

Comprehensive. Specification-mapped. Searchable. Editable. Identify and address common misunderstandings across the full KS3 Activate Biology course with a lesson-by-lesson misconceptions reference.

From speculation over mergers and acquisitions to the hype surrounding clinical readouts, it seems biotechnology stocks are all the rage this year. Shares rose 5% in after-hours trading on Tuesday as ...

Complete. Accurate. Structured. Searchable. Editable. Capture interest from the beginning of every lesson with a structured collection of lesson hooks showing how KS3 Activate Biology topics connect ...

The latest company to spin out of a Stanford Medicine lab is a biotech undertaking with 37,000 employees — and none of them are human. There’s no lab space, no lunch breaks and no payroll. It’s an ...

IntroductionIn our household, with a daughter currently attending an international school in Thailand, I often have the opportunity to hear people say, "I'm thinking about enrolling my junior high sch ...

Bipartisan legislation under review in Congress has the potential to significantly rejigger global drug development — and the biggest beneficiaries may not be American. The bill, titled the Biotech ...

The recent announcement of novel, viable viruses created by artificial intelligence (AI) was celebrated as a major advance in the fight against antibiotic resistance. But it also raised urgent ...

Mihwa Kim loved makeup so much that she became a host on a beauty home shopping show in South Korea — comparing, testing and promoting dozens of products on television. Then in 2013, her career was ...

As Legend Biotech's CEO suddenly resigned, the search is underway to identify a permanent successor. (Gerd Altmann/Pixabay) In a sudden leadership shift, Legend Biotech announced that its CEO, Ying ...

Dealmaking is back with a vengeance in the pharmaceutical sector this year. According to a report by PwC, there were more than $65 billion in pharma and life sciences mergers & acquisitions in the ...

Biotech investors are far more selective than they were during the pandemic-era boom, JPMorgan's top EMEA healthcare investment bankers told CNBC. Many biotech companies are now pursuing a dual-track ...